PXD071550-1

PXD071550 is an original dataset announced via ProteomeXchange.

Title	Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease
Description	Metabolic dysfunction-associated steatotic liver disease (MASLD) is a clinicopathological syndrome characterized by abnormal accumulation of fat within hepatocytes, and there is currently no standardized clinical treatment available. Consequently, there is an urgent need to discover new pharmacological interventions and to investigate novel therapeutic targets for MASLD. Melatonin, known for its multifaceted biological functions, has shown therapeutic potential for the treatment of MASLD. However, the underlying mechanisms remain unclear, particularly since the direct targets of melatonin have not yet been discovered. In our study, we found that melatonin significantly improved various indicators in a mouse MASLD model and protected palmitic acid induced mouse hepatocytes from lipid accumulation. We successfully identified and validated the mitochondrial trifunctional enzyme α-subunit HADHA as a binding target for melatonin using the cellular thermal shift assay (CETSA). This interaction enhances the expression of PGC-1α, which subsequently promotes mitochondrial biogenesis and accelerates lipid metabolism. In addition, melatonin reduces lipid accumulation and ameliorates MASLD through its regulatory effect on key proteins involved in fatty acid metabolism, including Acyl coenzyme A oxidase 1, CD36, and Fatty acid synthase. Importantly, these beneficial effects are diminished when HADHA is knocked down. In conclusion, our study suggests that melatonin ameliorates MASLD through HADHA-mediated regulation of mitochondrial biogenesis and lipid oxidation, highlighting its potential as a promising therapeutic agent for MASLD. These results lay a theoretical foundation and offer novel insights and strategies into the role of melatonin in the treatment of MASLD.
HostingRepository	PRIDE
AnnounceDate	2026-06-08
AnnouncementXML	Submission_2026-06-07_18:02:08.592.xml
DigitalObjectIdentifier
ReviewLevel	Peer-reviewed dataset
DatasetOrigin	Original dataset
RepositorySupport	Unsupported dataset by repository
PrimarySubmitter	Junzhe Zhang
SpeciesList	scientific name: Mus musculus (Mouse); NCBI TaxID: NEWT:10090;
ModificationList	TMT6plex-126 reporter+balance reagent acylated residue; monohydroxylated residue; iodoacetamide derivatized residue
Instrument	Orbitrap Fusion Lumos

Revision	Datetime	Status	ChangeLog Entry
0	2025-12-03 16:39:23	ID requested
⏵ 1	2026-06-07 18:02:09	announced

Zhu Y, Liu Y, Liu R, Zhang J, Meng Y, Liu L, Liu X, Liu D, Gu L, Zhong L, Xu X, Li Y, Xu J, Dai L, Shen S, Wang J, Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease. Mol Biomed, 7(1):(2026) [pubmed]

10.1186/s43556-026-00461-0;

submitter keyword: Melatonin,lipid metabolism,non-alcoholic steatotic liver disease

Yongping Zhu
contact affiliation	State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs, Artemisinin Research Center, and Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
contact email	ypzhu@icmm.ac.cn
lab head
Junzhe Zhang
contact affiliation	Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences
contact email	jzzhang@icmm.ac.cn
dataset submitter

Dataset FTP location NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2026/06/PXD071550

PRIDE project URI

• PRIDE
  1. PXD071550
     1. Label: PRIDE project
     2. Name: Melatonin targets mitochondrial trifunctional enzyme HADHA to improve lipid metabolism in metabolic dysfunction-associated steatotic liver disease